-transparent.png){kind=logo}
In a retrospective study, 58 patients with bowel obstruction due to advanced ovarian cancer were analysed. In a forward stepwise proportional hazard regression analysis, we looked for factors influencing bowel obstruction-free survival. Patients who presented with bowel obstruction as the first sign of ovarian cancer and those with a longer interval between last cancer treatment and bowel obstruction did better. Patients with ascites did worse. No other independent factors were found. Based on these data, we classified patients into a favourable prognosis group (no previous treatment or interval since last treatment exceeding 6 months; no ascites) and a poor prognosis group (interval since last treatment shorter than 6 months; ascites). Patients from the favourable prognosis group had a median bowel obstruction-free survival of 8 months, compared to 1 month for the poor prognosis group (P < 0.001). Surgery had a marginally significant positive effect on bowel obstruction-free survival when compared to medical treatment in the favourable prognosis group (P = 0.052). Surgery had no effect at all in the poor prognosis patients.
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
December 2005,
Gynecologic oncology,
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
January 2002,
Gynecologic oncology,
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
April 1994,
Journal of pain and symptom management,
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
March 2017,
Future oncology (London, England),
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
October 1996,
Zhonghua fu chan ke za zhi,
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
March 1983,
Obstetrics and gynecology,
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
April 2020,
Tumori,
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
July 1994,
Current opinion in oncology,
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
January 1993,
Annals of oncology : official journal of the European Society for Medical Oncology,
F A Zoetmulder, and
T J Helmerhorst, and
F van Coevorden, and
P E Wolfs, and
J P Leyer, and
A A Hart
January 2009,
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
